Clinical Operations and Innovation leaders in pharma companies of all sizes understand the change management involved in shifting from traditional SOPs to implementing a Decentralized Trial (DCT) with new roles and processes, and new technologies which are enabling the growing use of DCTs. 

Register for this webinar to understand the lessons learned during the past three years, including numerous vaccine trials, in delivering DCT on a global basis including:

  • How technology is ensuring efficient interactions throughout the trial
  • How new roles and processes are reducing site burden while optimizing the patient experience 
  • How DCTs are impacting sponsors, sites and the patient journey

Listen to Case Studies to obtain a broad understanding of how people, process and technology combine to implement an ideal DCT for sponsors, sites and patients.

Register Today

Featured Speakers

Jennifer Aquino

Vice President, RDS Technologies, Decentralized Trials
IQVIA

Jennifer is responsible for developing technology and technology-enabled services for Decentralized Trials (DCT). She was previously Chief Operating Officer for Cenduit, developing solutions to help sponsors manage randomization and drug supply activities as well as delivery services that support site and patient facing technologies.

Bill Gibson

Sr. Director, Product & Strategy, Decentralized Clinical Trials
IQVIA

Bill is responsible for managing the Decentralized Clinical Trials (DCT) services-technology partnership, providing product strategy and product management functions for the DCT Services business. Bill has been active in industry initiatives across the clinical development landscape including CDISC, SCDM, and PhUSE.

Date:  Tuesday, October 26, 2021
Time:  11am ET / 8am PT
Duration:  1 Hour

Register now for this webinar